Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Silent atrial fibrillation 

Silent atrial fibrillation
Chapter:
Silent atrial fibrillation
Author(s):

Ben Freedman

and Nicole Lowres

DOI:
10.1093/med/9780198784906.003.0500
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 October 2021

Silent or asymptomatic atrial fibrillation (AF) is common. It can occur in patients with symptomatic AF, where silent episodes often outweigh symptomatic episodes. It can also occur in patients who experience no symptoms at all, or who have non-specific AF symptoms. Silent AF may present with a stroke (approximately 9% of all ischaemic strokes) or with heart failure due to tachycardia-induced cardiomyopathy which responds to control of ventricular rate. Silent AF is often found during routine clinical examination by pulse palpation or routine electrocardiogram (ECG), or with implanted cardiac electronic devices which continuously sense atrial activity. Management of implanted device-detected AF is debated as the stroke risk is lower than symptomatic AF, particularly when episodes are brief. Silent AF may be detected by opportunistic screening, either at a single time point or by multiple patient-initiated recordings over 2 weeks. AF screening may utilize pulse palpation, photoplethysmography, modified sphygmomanometers, or handheld ECG devices. Because an ECG is required for a diagnosis, handheld ECG recorders with automated AF detection are now recommended. Screen-detected AF is not low risk and requires antithrombotic therapy. Screening for AF to prevent stroke has been shown to be cost-effective.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.